IRA TURNER
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- PLAINVIEW, NY
- NPI
- 1306822929
- Received
- $606,692 in 977 records, 2019 to 2023 ($596,811 general, $9,880 research)
- As principal investigator
- $58,436 of research payments to others in 21 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 3 | $182 |
| 2023 | Research payment | 1 | $940 |
| 2022 | General payment | 124 | $79,278 |
| 2021 | General payment | 312 | $208,879 |
| 2021 | Research payment | 1 | $4,878 |
| 2020 | General payment | 228 | $131,097 |
| 2020 | Research payment | 2 | $3,807 |
| 2019 | General payment | 305 | $177,373 |
| 2019 | Research payment | 1 | $254 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 238 | $429,184 |
| Consulting Fee | 32 | $77,737 |
| Travel and Lodging | 137 | $37,222 |
| Honoraria | 13 | $27,162 |
| Food and Beverage | 546 | $22,681 |
| Research payment | 5 | $9,880 |
| Grant | 3 | $2,587 |
| Education | 3 | $235 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-11-17 | ABBVIE INC. | $106 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-05-23 | PFIZER INC. | $940 | Research payment | In-kind items and services | NURTEC ODT Drug, PAIN | RIMEGEPANT CLINICAL PUBLICATION PROGRAM | 2023 |
| 2023-03-08 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-01-31 | ABBVIE INC. | $69 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2022-11-19 | ABBVIE INC. | $46 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-11-18 | ABBVIE INC. | $225 | Consulting Fee | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-11-17 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $78 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-11-10 | IMPEL PHARMACEUTICALS INC. | $750 | Consulting Fee | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-10-13 | IMPEL PHARMACEUTICALS INC. | $8,752 | Consulting Fee | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-10-13 | IMPEL PHARMACEUTICALS INC. | $1,500 | Consulting Fee | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-10-13 | IMPEL PHARMACEUTICALS INC. | $1,500 | Consulting Fee | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-10-13 | IMPEL PHARMACEUTICALS INC. | $68 | Food and Beverage | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-10-13 | IMPEL PHARMACEUTICALS INC. | $18 | Travel and Lodging | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-10-01 | IMPEL PHARMACEUTICALS INC. | $188 | Food and Beverage | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-09-30 | IMPEL PHARMACEUTICALS INC. | $749 | Travel and Lodging | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-09-30 | IMPEL PHARMACEUTICALS INC. | $146 | Food and Beverage | In-kind items and services | Trudhesa Drug, Migraine | 2022 | |
| 2022-09-08 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $1,500 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-08-11 | IMPEL PHARMACEUTICALS INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-07-29 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $40 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-07-27 | ABBVIE INC. | $562 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-07-27 | ABBVIE INC. | $562 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-07-15 | ABBVIE INC. | $50 | Food and Beverage | In-kind items and services | BOTOX Biological, FACIAL AESTHETICS | 2022 | |
| 2022-07-06 | IMPEL PHARMACEUTICALS INC. | $1,000 | Consulting Fee | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-06-30 | ABBVIE INC. | $562 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-06-28 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-06-28 | ABBVIE INC. | $662 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-06-28 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-06-24 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-06-24 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-06-07 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-05-26 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $1,500 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-05-23 | Lundbeck LLC | $1,275 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-05-23 | ABBVIE INC. | $562 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-05-18 | ABBVIE INC. | $562 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-05-11 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-05-11 | ABBVIE INC. | $748 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-05-11 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-05-07 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $6,500 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-05-07 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $301 | Travel and Lodging | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-05-07 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $135 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $2,812 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $264 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $188 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $148 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $47 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $38 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-30 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-29 | ABBVIE INC. | $117 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-29 | ABBVIE INC. | $36 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-04-29 | Allergan, Inc. | $20 | Food and Beverage | In-kind items and services | BOTOX Biological, FACIAL AESTHETICS | 2022 | |
| 2022-04-28 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-04-27 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-27 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $20 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-26 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-26 | Lundbeck LLC | $2,550 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-04-26 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $125 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-25 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-04-20 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-04-19 | IMPEL PHARMACEUTICALS INC. | $2,396 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-04-13 | Lundbeck LLC | $124 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-04-12 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-04-12 | Lundbeck LLC | $14 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-04-11 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2022 | |
| 2022-04-09 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $304 | Travel and Lodging | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-08 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $28 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-07 | IMPEL PHARMACEUTICALS INC. | $2,396 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-04-06 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-04-06 | ABBVIE INC. | $116 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-04-05 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-04-05 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-04-05 | Teva Pharmaceuticals USA, Inc. | $9 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2022 | |
| 2022-04-01 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-04-01 | Allergan, Inc. | $5 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-03-31 | IMPEL PHARMACEUTICALS INC. | $2,396 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-03-30 | Teva Pharmaceuticals USA, Inc. | $34 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-03-30 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-03-25 | Lilly USA, LLC | $2,587 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EMGALITY Drug, Neuroscience | 2022 | |
| 2022-03-24 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-03-23 | Merz Pharmaceuticals, LLC | $34 | Food and Beverage | In-kind items and services | Xeomin Biological, Musculoskeletal | 2022 | |
| 2022-03-22 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-03-22 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-03-21 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-03-17 | Lundbeck LLC | $12 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-03-16 | BioDelivery Sciences International, Inc. | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ELYXYB - celecoxib Drug, Migraine | 2022 | |
| 2022-03-16 | Lilly USA, LLC | $43 | Grant | Cash or cash equivalent | EMGALITY Drug, Neuroscience | 2022 | |
| 2022-03-16 | Lilly USA, LLC | $43 | Grant | Cash or cash equivalent | EMGALITY Drug, Neuroscience | 2022 | |
| 2022-03-15 | Amgen Inc. | $28 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2022 | |
| 2022-03-15 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-03-14 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-03-10 | Allergan, Inc. | $22 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-03-09 | ABBVIE INC. | $117 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-03-08 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-03-08 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2022 | |
| 2022-03-04 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $3 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-03-03 | UPSHER-SMITH LABORATORIES LLC | $12 | Food and Beverage | In-kind items and services | TOSYMRA Drug, NEUROLOGY | 2022 | |
| 2022-03-02 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $24 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-03-01 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-02-24 | IMPEL PHARMACEUTICALS INC. | $2,396 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trudhesa Drug, Migraine | 2022 | |
| 2022-02-23 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-02-23 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-02-22 | EMD Serono, Inc. | $20 | Food and Beverage | Cash or cash equivalent | 2022 | ||
| 2022-02-17 | ABBVIE INC. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-02-15 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2022 | |
| 2022-02-15 | Allergan, Inc. | $15 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-02-10 | ABBVIE INC. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-02-10 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-02-09 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-02-09 | Allergan, Inc. | $19 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2022 | |
| 2022-02-08 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2022 | |
| 2022-02-04 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2022 | |
| 2022-02-01 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-01-27 | Allergan, Inc. | $3,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2022 | |
| 2022-01-27 | Merz Pharmaceuticals, LLC | $42 | Food and Beverage | In-kind items and services | Xeomin Biological, Musculoskeletal | 2022 | |
| 2022-01-26 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-01-25 | Lundbeck LLC | $2,550 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-01-24 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-01-24 | Currax Pharmaceuticals LLC | $16 | Food and Beverage | In-kind items and services | CONTRAVE Drug, Obesity | 2022 | |
| 2022-01-20 | UPSHER-SMITH LABORATORIES LLC | $28 | Food and Beverage | In-kind items and services | TOSYMRA Drug, NEUROLOGY | 2022 | |
| 2022-01-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-01-19 | ABBVIE INC. | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-01-18 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2022 | |
| 2022-01-12 | Amgen Inc. | $675 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2022 | |
| 2022-01-12 | Lundbeck LLC | $125 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-01-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-01-11 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-01-11 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2022 | |
| 2022-01-06 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2022 | |
| 2022-01-05 | ABBVIE INC. | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2021-12-22 | Amgen Inc. | $1,273 | Travel and Lodging | In-kind items and services | Aimovig Biological, Neuroscience | 2021 | |
| 2021-12-22 | UPSHER-SMITH LABORATORIES LLC | $29 | Food and Beverage | In-kind items and services | TOSYMRA Drug, NEUROLOGY | 2021 | |
| 2021-12-21 | Allergan, Inc. | $20 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2021 | |
| 2021-12-20 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2021 | |
| 2021-12-16 | ABBVIE INC. | $3,360 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $1,920 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $725 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $473 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $280 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $168 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $167 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $118 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $72 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $28 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-16 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-15 | Allergan, Inc. | $21 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2021 | |
| 2021-12-14 | Amgen Inc. | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2021 | |
| 2021-12-14 | Amgen Inc. | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2021 | |
| 2021-12-14 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2021 | |
| 2021-12-13 | Genentech USA, Inc. | $15 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2021 | |
| 2021-12-09 | Amgen Inc. | $122 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2021 | |
| 2021-12-09 | Biohaven Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-12-08 | BioDelivery Sciences International, Inc. | $2,500 | Honoraria | Cash or cash equivalent | ELYXYB - CELECOXIB Drug, Pain Management | 2021 | |
| 2021-12-08 | Biohaven Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-12-08 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2021 | |
| 2021-12-07 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2021 | |
| 2021-12-06 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-12-02 | Allergan, Inc. | $3,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2021 | |
| 2021-12-01 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-11-30 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2021 | |
| 2021-11-23 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-11-22 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2021 | |
| 2021-11-19 | ABBVIE INC. | $450 | Consulting Fee | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-11-19 | Allergan, Inc. | $300 | Consulting Fee | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2021 | |
| 2021-11-19 | Biohaven Pharmaceuticals, Inc. | $122 | Food and Beverage | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-11-19 | Allergan, Inc. | $40 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2021 | |
| 2021-11-19 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | EMGALITY Drug, Neuroscience | 2021 | |
| 2021-11-18 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-11-17 | Biohaven Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-11-17 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2021 | |
| 2021-11-17 | Genentech USA, Inc. | $15 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2021 | |
| 2021-11-16 | Biohaven Pharmaceuticals, Inc. | $2,500 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-11-10 | Allergan, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2021 | |
| 2021-11-10 | Allergan, Inc. | $688 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2021 | |
| 2021-11-10 | Allergan, Inc. | $130 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2021 | |
| 2021-11-10 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-11-09 | Allergan, Inc. | $13 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2021 | |
| 2021-11-04 | Allergan, Inc. | $19 | Food and Beverage | In-kind items and services | BOTOX Biological, HYPERHYDROSIS | 2021 | |
| 2021-11-01 | Lundbeck LLC | $2,550 | Honoraria | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2021 | |
| 2021-10-28 | Biohaven Pharmaceuticals, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-10-28 | Biohaven Pharmaceuticals, Inc. | $87 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-10-28 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2021 | |
| 2021-10-26 | Teva Pharmaceuticals USA, Inc. | $3,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AJOVY Biological, Central Nervous System | 2021 | |
| 2021-10-26 | Teva Pharmaceuticals USA, Inc. | $118 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2021 | |
| 2021-10-26 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2021 | |
| 2021-10-22 | ABBVIE INC. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-22 | ABBVIE INC. | $666 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-22 | ABBVIE INC. | $79 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-22 | ABBVIE INC. | $45 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-22 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-10-21 | ABBVIE INC. | $2,880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $3,360 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $538 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $356 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $227 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $203 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $148 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $90 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $84 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $23 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $19 | Food and Beverage | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $3 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 |
The latest 200 records of 977.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2022-02-15 | Novartis Pharmaceuticals Corporation | ISLAND NEUROLOGICAL A DIVISION PROHEALTH CARE ASSOCIATES LLP CFTY720D2403 | $1,240 | AN OPEN-LABEL MULTICENTER SINGLE-ARM PILOT STUDY TO ASSESS IMMUNE RESPONSE TO COVID-19 VACCINE IN PARTICIPANTS WITH RELA | 2022 |
| 2022-02-09 | Eli Lilly and Company | PROHEALTH MEDICAL MANAGEMENT LLC | $4,218 | PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | 2022 |
| 2022-01-31 | Amgen Inc. | ISLAND NEUROLOGICAL ASSOCIATES | $5,075 | US Pt Satisfaction | 2022 |
| 2022-01-25 | Amgen Inc. | ISLAND NEUROLOGICAL ASSOCIATES | $5,652 | US Pt Satisfaction | 2022 |
| 2021-12-02 | Biohaven Pharmaceuticals, Inc. | PROHEALTHCARE ASSOCIATES LLP | $500 | A Phase 2/3 Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migrai | 2021 |
| 2021-12-02 | Biohaven Pharmaceuticals, Inc. | PROHEALTHCARE ASSOCIATES LLP | $2,500 | A Phase 2/3 Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migrai | 2021 |
| 2021-10-28 | Amgen Inc. | ISLAND NEUROLOGICAL ASSOCIATES | $5,110 | US Pt Satisfaction | 2021 |
| 2021-06-11 | Eli Lilly and Company | PROHEALTH MEDICAL MANAGEMENT LLC | $9,037 | PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | 2021 |
| 2021-05-27 | Biohaven Pharmaceuticals, Inc. | PROHEALTHCARE ASSOCIATES LLP | $1,220 | A Phase 2/3 Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Mig | 2021 |
| 2020-07-09 | Eli Lilly and Company | ISLAND NEUROLOGICAL A DIVISION OF PRO HEALTH CARE ASSOCIATES LLP | $10 | RANDOMIZED CONTROLLED TRIAL OF LASMIDITAN OVER FOUR MIGRAINE ATTACKS | 2020 |
| 2020-03-03 | Eli Lilly and Company | ISLAND NEUROLOGICAL A DIVISION OF PRO HEALTH CARE ASSOCIATES LLP | $3,242 | RANDOMIZED CONTROLLED TRIAL OF LASMIDITAN OVER FOUR MIGRAINE ATTACKS | 2020 |
| 2019-07-22 | Amgen Inc. | ISLAND NEUROLOGICAL ASSOCIATES | $90 | Phase 3 Pivotal EMP (STRIVE) | 2019 |
| 2019-06-17 | Eli Lilly and Company | ISLAND NEUROLOGICAL ASSOCIATES PC | $164 | RANDOMIZED CONTROLLED TRIAL OF LASMIDITAN OVER FOUR MIGRAINE ATTACKS | 2019 |
| 2019-06-10 | Eli Lilly and Company | ISLAND NEUROLOGICAL A DIVISION OF PRO HEALTH CARE ASSOCIATES LLP | $749 | RANDOMIZED CONTROLLED TRIAL OF LASMIDITAN OVER FOUR MIGRAINE ATTACKS | 2019 |
| 2019-06-03 | Amgen Inc. | ISLAND NEUROLOGICAL ASSOCIATES, PC | $245 | P2 Migraine Proof of Concept | 2019 |
| 2019-04-08 | Amgen Inc. | ISLAND NEURO ASSOCIATES | $2 | P2 Migraine Proof of Concept | 2019 |
| 2019-02-11 | Teva Pharmaceuticals USA, Inc. | Island Neurological a division of Prohealth Care Associates, P.C. | $3,720 | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Prev | 2019 |
| 2019-01-26 | Amgen Inc. | PROHEALTH CARE ASSOCIATES LLP A DIVISION OF PROHEALTH CARE ASSOCIATES LLP | $2,582 | P2 Migraine Proof of Concept | 2019 |
| 2019-01-22 | Allergan, Inc. | PROHEALTH CARE ASSOCIATES LLP | $6,500 | A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY | 2019 |
| 2019-01-22 | Allergan, Inc. | PROHEALTH CARE ASSOCIATES LLP | $6,500 | A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY | 2019 |
| 2019-01-01 | Amgen Inc. | PROHEALTH CARE ASSOCIATES, LLP | $77 | P2 Migraine Proof of Concept | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Plainview, NY, county Nassau County, NY, state New York; placed by its city name.
| Measure | Place (city or town) Plainview, NY | County Nassau County, NY | State New York |
|---|---|---|---|
| Population B01003 | 25,982 | 1,389,591 | 19,852,366 |
| Population, 2020 census P1 | 27,100 | 1,395,774 | 20,201,249 |
| Median age B01002 | 45.2 | 42.0 | 39.8 |
| Under 18 B01001 | 23.3% | 21.5% | 20.5% |
| 65 and over B01001 | 22.9% | 18.7% | 17.9% |
| Households B11001 | 8,748 | 458,166 | 7,722,646 |
| Foreign born B05002 | 18.0% | 23.3% | 22.8% |
| Median household income B19013 | $189,906 | $146,202 | $85,974 |
| Median family income B19113 | $217,813 | $169,137 | $106,873 |
| Per capita income B19301 | $77,436 | $64,198 | $50,712 |
| Poverty rate B17001 | 2.9% | 5.4% | 14.0% |
| Unemployment rate B23025 | 3.7% | 4.8% | 6.4% |
| Civilian labor force B23025 | 13,240 | 730,034 | 10,171,766 |
| Mean commute (minutes) B08013 | 35.3 | 36.0 | 32.6 |
| Bachelor's degree or higher B15003 | 68.4% | 49.7% | 40.2% |
| Housing units B25001 | 9,078 | 479,044 | 8,585,241 |
| Owner-occupied B25003 | 92.5% | 81.9% | 54.3% |
| Renters B25003 | 7.5% | 18.1% | 45.7% |
| Median home value B25077 | $796,300 | $684,700 | $423,800 |
| Median gross rent B25064 | $3,392 | $2,252 | $1,621 |
| White, not Hispanic B03002 | 69.3% | 54.3% | 52.8% |
| Black B03002 | 0.5% | 10.8% | 13.4% |
| Hispanic or Latino B03002 | 5.7% | 18.7% | 19.8% |
| Asian B03002 | 22.4% | 12.2% | 9.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Plainview, NY.
Comments